Online citations, reference lists, and bibliographies.
← Back to Search

Defective Brain Energy Metabolism Shown By In Vivo 31P MR Spectroscopy In 28 Patients With Mitochondrial Cytopathies

B. Barbiroli, P. Montagna, P. Martinelli, R. Lodi, S. Iotti, P. Cortelli, R. Funicello, P. Zaniol
Published 1993 · Biology, Medicine

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
We studied brain energy metabolism by phosphorus magnetic resonance spectroscopy (31P MRS) in 28 patients with mitochondrial cytopathies, and 20 normal control subjects. Fourteen patients had myopathy alone, six had only mild brain symptoms, and eight showed different degrees of brain involvement. Brain 31P MRS showed a low phosphocreatine content in all patients, accompanied by a high inorganic phosphate in 14 of 28 patients. The average value of the Pi concentration in the patient group was significantly (p = 0.009) different from the control group. The cytosolic pH was normal. From these data were derived a high concentration of ADP (calculated from the creatine kinase equilibrium), a high percent value of V/Vmax for ATP biosynthesis, and a low phosphorylation potential, all features showing a derangement of brain energy metabolism, in all patients with mitochondrial cytopathies. 31P MRS proved to be sensitive enough to disclose a deficit of mitochondrial functionality not only in the affected patients, but also in those without clinically evident brain symptoms.
This paper references
Respiratory enzymes in oxidative phosphorylation. I. Kinetics of oxygen utilization.
B. Chance (1955)
10.1016/0022-510X(73)90054-3
Ophthalmoplegia plus with morphological and chemical studies of cerebellar and muscle tissue.
L. Schneck (1973)
10.1002/ANA.410010104
Lumping or splitting? “ophthalmoplegia‐plus” or kearns‐sayre syndrome?
R. A. Berenberg (1977)
10.1016/s0021-9258(18)50401-4
Cytosolic phosphorylation potential.
R. Veech (1979)
10.1111/J.1471-4159.1981.TB02393.X
The Metabolism of Purine and Pyrimidine Nucleotides in Rat Cortex During Insulin‐Induced Hypoglycemia and Recovery
A. Chapman (1981)
10.1002/ANA.410160409
Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: A distinctive clinical syndrome
S. Pavlakis (1984)
10.1016/0022-2364(84)90179-3
Depth-resolved surface-coil spectroscopy (DRESS) for in Vivo 1H, 31P, and 13C NMR
P. Bottomley (1984)
10.1212/WNL.35.12.1681
Cerebral metabolism in hyper‐ and hypocarbia
O. Petroff (1985)
10.1073/PNAS.82.24.8384
Control of oxidative metabolism and oxygen delivery in human skeletal muscle: a steady-state analysis of the work/energy cost transfer function.
B. Chance (1985)
Control of oxidative phosphorylation and oxygen delivery in human skeletal muscle: A steady-state analysis of the work/energy cost transfer function
B Chance (1985)
10.1073/PNAS.83.24.9458
Multiple controls of oxidative metabolism in living tissues as studied by phosphorus magnetic resonance.
B. Chance (1986)
Presentation of metabolic dis­ eases. In: Diseases of the Nervous System: Clinical Neuro­ biology (Asbury AK
Hurko (1986)
Presentation of metabolic dis­ eases. In: Diseases of the Nervous System: Clinical Neuro­ biology (Asbury AK
Hurko (1986)
Presentation of metabolic dis ­ eases
GM McKann (1986)
10.1152/JAPPL.1987.62.5.2094
Relationship between intracellular pH and energy metabolism in dog brain as measured by 31P-NMR.
S. Nioka (1987)
10.1007/BF01812852
Mitochondrial myopathies
S. Dimauro (1987)
10.1002/MRM.1910050102
31P magnetization transfer studies of creatine kinase kinetics in living rabbit brain
H. Degani (1987)
Metabolic consequences of oxygen transport studied with phosphorus magnetic reso­ nance spectroscopy
BJ Clark (1987)
Metabolic consequences of oxygen transport studied with phosphorus magnetic reso­ nance spectroscopy
BJ Clark (1987)
10.1093/BRAIN/111.5.1009
The cerebral metabolism of glucose and oxygen measured with positron tomography in patients with mitochondrial diseases.
R. Frackowiak (1988)
10.1002/MRM.1910070110
A simple method for processing NMR spectra in which acquisition is delayed: Applications to in vivo localized 31P NMR spectra acquired using the DRESS technique
T. Allman (1988)
10.1111/j.1471-4159.1988.tb04850.x
High‐Resolution Proton Magnetic Resonance Spectroscopy of Rabbit Brain: Regional Metabolite Levels and Postmortem Changes
O. Petroff (1988)
10.1016/0092-8674(88)90218-8
Familial mitochondrial encephalomyopathy (MERRF): Genetic, pathophysiological, and biochemical characterization of a mitochondrial DNA disease
D. Wallace (1988)
3Ip_NMR spectros­ copy in the newborn
M Delivoria-Papadopulos (1988)
10.1093/CLINCHEM/35.3.392
Rapid, reliable in vivo assays of human phosphate metabolites by nuclear magnetic resonance.
P. Bottomley (1989)
10.1093/BRAIN/112.5.1231
Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study.
S. Berkovic (1989)
Myoclonus ep­ ilepsy and ragged-red fibres (MERRF): A clinical, patholog­ ical, biochemical, magnetic resonance spectrographic
SF Berkovic (1989)
A new mitochondrial disease associated with mitochondrial DNA heteroplasmy.
I. Holt (1990)
10.1002/ANA.410280620
Phosphorus magnetic resonance spectroscopy of brain in mitochondrial cytopathies
P. Matthews (1990)
10.1002/ANA.410270607
Phosphorus magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine
S. M. Eleff (1990)
10.1046/J.1468-2982.1991.1103160.X
Complicated migraine studied by phosphorus magnetic resonance spectroscopy.
E. Presedo (1991)
10.1212/WNL.41.8.1211
Leber's hereditary optic neuropathy
P. Cortelli (1991)
10.1016/0022-510X(91)90308-T
Muscle mitochondrial DNA deletion and 31P-NMR spectroscopy alterations in a migraine patient
N. Bresolin (1991)
10.1002/ANA.410290416
In vivo magnetic resonance spectroscopy of brain and muscle in a type of mitochondrial encephalomyopathy (MERRF)
P. Matthews (1991)
Results of a multi-centre trial of test objects for localized in vivo NMR spectroscopy
SF Keevil (1991)
A test object for quality control of 31p_MRS probes and localization techniques in a whole­ body imager-spectrometer
B Barbiroli (1991)
Leber's hereditary optic neuropathy: Ge­ netic, biochemical, and phosphorus magnetic resonance spectroscopy study in an Italian family
P Cortelli (1991)
10.1212/WNL.42.6.1209
Abnormal brain and muscle energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura
B. Barbiroli (1992)
10.1002/ANA.410310422
Brain 31P‐magnetic resonance spectroscopy in mitochondrial cytopathies
P. Montagna (1992)



This paper is referenced by
10.3390/life11050415
The Role of Metabolism in Migraine Pathophysiology and Susceptibility
Olivia Grech (2021)
10.1093/brain/awaa340
Magnetic resonance spectroscopy reveals mitochondrial dysfunction in amyotrophic lateral sclerosis.
Matilde Sassani (2020)
10.1111/head.13935
Migraine as a Cortical Brain Disorder
P. Barbanti (2020)
10.1080/00387010.2018.1430703
Computation and conversion of brain pH values obtained with two algorithms of phosphorus magnetic resonance spectroscopy data analysis
Monika Cichocka (2018)
10.1002/1873-3468.12920
Translational approaches to restoring mitochondrial function in Parkinson's disease
H. Mortiboys (2018)
10.1042/EBC20170109
Neuroimaging in mitochondrial disorders.
M. Mascalchi (2018)
10.1097/WCO.0000000000000436
Migraine and magnetic resonance spectroscopy: a systematic review
Samaira Younis (2017)
10.1016/j.schres.2016.10.037
Neurobiological basis of bipolar disorder: Mitochondrial dysfunction hypothesis and beyond
Tadafumi Kato (2017)
10.1159/000478723
Cerebrospinal Fluid Phosphate in Delirium after Hip Fracture
Ane-Victoria Idland (2017)
10.1093/brain/awx168
Monitoring clinical progression with mitochondrial disease biomarkers
H. Steele (2017)
10.1007/s10334-016-0524-9
31P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results
C. Mirkes (2016)
Neural basis of visual cortical reorganization mechanisms after retinal injury in optic neuropathies
Otília C. d'Almeida (2016)
Molecular genetic investigation of mitochondrial dysfunction in relation to migraine susceptibility
S. Stuart (2015)
10.12659/PJR.895178
PH Measurements of the Brain Using Phosphorus Magnetic Resonance Spectroscopy (31PMRS) in Healthy Men – Comparison of Two Analysis Methods
Monika Cichocka (2015)
10.1016/j.pscychresns.2014.04.002
Effect of altitude on brain intracellular pH and inorganic phosphate levels
Xianfeng Shi (2014)
10.1016/j.drugalcdep.2012.09.015
Decreased frontal lobe phosphocreatine levels in methamphetamine users.
Younghoon Sung (2013)
10.1177/0004867412449303
Mitochondrial modulators for bipolar disorder: A pathophysiologically informed paradigm for new drug development
A. Nierenberg (2013)
10.1016/j.spen.2013.09.002
Mitochondrial dysfunction in migraine.
William R Yorns (2013)
10.1007/s00438-012-0723-7
A possible role for mitochondrial dysfunction in migraine
S. Stuart (2012)
10.1177/0333102412452048
Magnetic resonance spectroscopy in migraine: What have we learned so far?
H. Reyngoudt (2012)
10.1093/brain/aws303
The human OPA1delTTAG mutation induces premature age-related systemic neurodegeneration in mouse.
E. Sarzi (2012)
10.1007/978-0-85729-701-3_13
Potential Therapies for Mitochondrial Dysfunction
C. Henchcliffe (2012)
10.2174/092986711797379221
Mitochondrial alterations and neuropsychiatric disorders.
D. Marazziti (2011)
10.1007/s00415-011-6117-7
Energy failure in multiple sclerosis and its investigation using MR techniques
D. Paling (2011)
10.1016/J.NEURAD.2009.07.001
Spectroscopie du phosphore 31 par résonance magnétique : applications en pathologies cérébrales
C. Menuel (2010)
10.1002/9780470034590.EMRSTM1106
Inherited Disease Studies by NMR
R. A. Iles (2010)
10.1016/j.neurad.2009.07.001
[Phosphorus magnetic resonance spectroscopy: Brain pathologies applications].
C. Menuel (2010)
10.1002/9780470661277.CH18
Mitochondrial Dysfunction and Oxidative Stress
T. Kato (2010)
10.1093/brain/awp293
Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease.
E. Hattingen (2009)
10.1007/978-3-7643-8567-5_6
Understanding the neurobiology of bipolar depression
J. Wang (2009)
Alterazioni mitocondriali e patologie psichiatriche Mitochondrial dysfunctions and psychiatric disorders
D. Marazziti (2009)
10.1016/j.mito.2008.05.003
Neuroimaging of mitochondrial disease.
R. Saneto (2008)
See more
Semantic Scholar Logo Some data provided by SemanticScholar